Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia

Archive ouverte

Antony-Debré, Iléana | Manchev, Vladimir, T | Balayn, Nathalie | Bluteau, Dominique | Tomowiak, Cécile | Legrand, Céline | Langlois, Thierry | Bawa, Olivia | Tosca, Lucie | Tachdjian, Gérard | Leheup, Bruno | Debili, Najet | Plo, Isabelle | Mills, Jason, A | French, Deborah | Weiss, Mitchell, J | Solary, Eric | Favier, Rémi | Vainchenker, William | Raslova, Hana

Edité par CCSD ; American Society of Hematology -

International audience. A half loss of RUNX1 activity leads to defects in primitive erythropoiesis, megakaryopoiesis, and proplatelet formation. • An almost complete loss of RUNX1 activity leads to the amplification of the granulomonocytic compartment with increased genomic instability. To explore how RUNX1 mutations predispose to leukemia, we generated induced plu-ripotent stem cells (iPSCs) from 2 pedigrees with germline RUNX1 mutations. The first, carrying a missense R174Q mutation, which acts as a dominant-negative mutant, is associated with thrombocytopenia and leukemia, and the second, carrying a monoallelic gene deletion inducing a haploinsufficiency, presents only as thrombocytopenia. Hema-topoietic differentiation of these iPSC clones demonstrated profound defects in eryth-ropoiesis and megakaryopoiesis and deregulated expression of RUNX1 targets. iPSC clones from patients with the R174Q mutation specifically generated an increased amount of granulomonocytes, a phenotype reproduced by an 80% RUNX1 knockdown in the H9 human embryonic stem cell line, and a genomic instability. This phenotype, found only with a lower dosage of RUNX1, may account for development of leukemia in patients. Altogether, RUNX1 dosage could explain the differential phenotype according to RUNX1 mutations, with a haploinsufficiency leading to thrombocytopenia alone in a majority of cases whereas a more complete gene deletion predisposes to leukemia.

Suggestions

Du même auteur

Disrupted filamin A/αIIbβ3 interaction induces macrothrombocytopenia by increasing RhoA activity

Archive ouverte | Donada, Alessandro | CCSD

International audience. Abstract Filamin A (FLNa) links the cell membrane with the cytoskeleton and is central in several cellular processes. Heterozygous mutations in the X-linked FLNA gene are associated with a la...

Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation

Archive ouverte | Bluteau, Dominique | CCSD

International audience. Point mutations in the 5′ UTR of ankyrin repeat domain 26 (ANKRD26) are associated with familial throm-bocytopenia 2 (THC2) and a predisposition to leukemia. Here, we identified underlying me...

ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis

Archive ouverte | Basso-Valentina, Francesca | CCSD

International audience. Sustained ANKRD26 expression associated with germline ANKRD26 mutations causes thrombocytopenia 2 (THC2), an inherited platelet disorder associated with a predisposition to leukemia. Some pat...

Chargement des enrichissements...